"10.1371_journal.pone.0046191","none","2012-10-02T00:00:00Z","Chloe I Bloom; Christine M Graham; Matthew P R Berry; Katalin A Wilkinson; Tolu Oni; Fotini Rozakeas; Zhaohui Xu; Jose Rossello-Urgell; Damien Chaussabel; Jacques Banchereau; Virginia Pascual; Marc Lipman; Robert J Wilkinson; Anne Oâ€™Garra","Division of Immunoregulation, MRC National Institute for Medical Research, London, United Kingdom; Division of Mycobacterial Research, MRC National Institute for Medical Research, London, United Kingdom; Department of Respiratory Medicine, Imperial College Healthcare NHS Trust, London, United Kingdom; Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Department of Medicine, Wright Fleming Institute, Imperial College, London, United Kingdom; Baylor Institute for Immunology Research/ANRS Center for Human Vaccines, INSERM, Dallas, Texas, United States of America; Systems Immunology, Benaroya Research Institute, Seattle, Washington, United States of America; Department of Thoracic Medicine, Royal Free Hospital NHS Trust, London, United Kingdom","Conceived and designed the experiments: AOG RJW DC JB VP MPRB. Performed the experiments: CIB CMG KAW TO FR ML. Analyzed the data: CIB ZX JRU. Contributed reagents/materials/analysis tools: ZX VP DC AOG RJW JB. Wrote the paper: CIB MPRB JRU DC ML RJW AOG.","The authors declare that co-author Robert J Wilkinson is a PLOS ONE Editorial Board member. They also confirm that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the PLOS ONE guide for authors and therefore will not alter their policy on data-sharing and materials. The authors declare their patent with details as shown here. U.S. Patent Application. Title: Early Detection of Tuberculosis Treatment Response. Serial No.: 61/610,121. Filing Date: March 13, 2012. Our File No.: BHCS:1146. There are no other relevant declarations relating to employment, consultancy, patents, products in development or modified products etc. Furthermore, the authors also confirm that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors. Dr. Jacques Banchereau no longer works at Hoffmann-La Roche Inc. as of the last month, but is still affiliated with Baylor Institute for Immunology Research. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2012","10","Chloe I Bloom","CIB",14,TRUE,6,6,3,7,TRUE,TRUE,FALSE,0,NA,FALSE
